An increasing body of evidence reveals that AKR1C1 shows a higher expression in a wide variety of cancers, including lung cancer, gastric cancer, and cervical cancer, than normal corresponding tissues (Hong et al., 2018). This evidence concerns the gene AKR1C1 and lung cancer.